PAM16 and cancer: MAGMAS has also been reported to be overexpressed in aggressive tumors, including prostate, ovarian, and central nervous system tumors [33,34,35], suggesting that MAGMAS overexpression may play a significant role in acquired treatment resistance in these cancers.